ABVC Biopharma Inc ABVC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:51 AM EDT
1.05quote price arrow down-0.04 (-3.67%)
Volume
18,778
52 week range
0.67 - 9.60
Loading...
  • Open1.06
  • Day High1.09
  • Day Low1.05
  • Prev Close1.09
  • 52 Week High9.60
  • 52 Week High Date05/09/23
  • 52 Week Low0.67
  • 52 Week Low Date10/06/23

Key Stats

  • Market Cap11.088M
  • Shares Out10.56M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-7.76

KEY STATS

  • Open1.06
  • Day High1.09
  • Day Low1.05
  • Prev Close1.09
  • 52 Week High9.60
  • 52 Week High Date05/09/23
  • 52 Week Low0.67
  • 52 Week Low Date10/06/23
  • Market Cap11.088M
  • Shares Out10.56M
  • 10 Day Average Volume0.54M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-7.76

RATIOS/PROFITABILITY

  • EPS (TTM)-2.52
  • P/E (TTM)-0.42
  • Fwd P/E (NTM)-1.62
  • EBITDA (TTM)-8.188M
  • ROE (TTM)-183.09%
  • Revenue (TTM)152,429.998
  • Gross Margin (TTM)-98.15%
  • Net Margin (TTM)-7,157.57%
  • Debt To Equity (MRQ)17.51%

EVENTS

  • Earnings Date05/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ABVC Biopharma Inc

 

Profile

MORE
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical...
Eugene Jiang
Chairman of the Board, Chief Business Officer
Uttam Patil
Chief Executive Officer
Leeds Chow
Chief Financial Officer, Principal Accounting Officer
Address
44370 Old Warm Springs Blvd
Fremont, CA
94538-6148
United States

Top Peers

SYMBOLLASTCHG%CHG
NTBL
Notable Labs Ltd
1.15-0.03-2.92%
CANF
Can Fite Biopharma Ltd
2.10+0.03+1.51%
GNPX
Genprex Inc
2.43+0.08+3.23%
IKT
Inhibikase Therapeutics Inc
2.19UNCHUNCH
LGVN
Longeveron Inc
2.65-0.28-9.42%